Christophe J. Queval
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Enabling the synthesis of multi-payload thio-antibody conjugates through the use of pyridazinediones, p-anisidine derivatives and various click chemistries.
Journal: RSC chemical biology
Published: January 20, 2026
IFITM1 differentially regulates antibacterial immunity and immunopathology but is dispensable for antiparasitic responses.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 29, 2025
Vinorelbine enhances the efficacy of oncolytic vaccinia virus in a preclinical model of ovarian high-grade serous carcinoma.
Journal: Molecular therapy. Oncology
Published: February 12, 2025
ATG9A and ARFIP2 cooperate to control PI4P levels for lysosomal repair.
Journal: Developmental cell
Published: October 01, 2024
Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Journal: Journal of neuroinflammation
Published: March 30, 2023
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Journal: Cell reports. Medicine
Published: June 06, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Journal: Cancer cell
Published: April 12, 2022
Tirap controls Mycobacterium tuberculosis phagosomal acidification.
Journal: PLoS pathogens
Published: April 08, 2022
Editorial: Recent Advances in Bovine Tuberculosis.
Journal: Frontiers in veterinary science
Published: March 29, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Journal: Cancer cell
Published: December 30, 2021
Three-dose vaccination elicits neutralising antibodies against omicron.
Journal: Lancet (London, England)
Published: December 29, 2021
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Journal: Lancet (London, England)
Published: December 29, 2021
Last Updated: 09/26/2026